Use of CAR-Transduced Natural Killer Cells in CD19-Positive Lymphoid Tumors-Reference-Cited by-同舟云学术

Use of CAR-Transduced Natural Killer Cells in CD19-Positive Lymphoid Tumors

Published:2020-02-06 Issue:6 Volume:382 Page:545-553
ISSN:0028-4793
Container-title:New England Journal of Medicine
language:en
Short-container-title:N Engl J Med

Author:

Liu Enli¹,Marin David¹,Banerjee Pinaki¹,Macapinlac Homer A.¹,Thompson Philip¹,Basar Rafet¹,Nassif Kerbauy Lucila¹,Overman Bethany¹,Thall Peter¹,Kaplan Mecit¹,Nandivada Vandana¹,Kaur Indresh¹,Nunez Cortes Ana¹,Cao Kai¹,Daher May¹,Hosing Chitra¹,Cohen Evan N.¹,Kebriaei Partow¹,Mehta Rohtesh¹,Neelapu Sattva¹,Nieto Yago¹,Wang Michael¹^ORCID,Wierda William¹,Keating Michael¹,Champlin Richard¹,Shpall Elizabeth J.¹,Rezvani Katayoun¹

Affiliation:

1. From the Departments of Stem Cell Transplantation and Cellular Therapy (E.L., D.M., P.B., R.B., L.N.K., B.O., M. Kaplan, V.N., I.K., A.N.C., M.D., C.H., P.K., R.M., Y.N., R.C., E.J.S., K.R.), Nuclear Medicine (H.A.M.), Leukemia (P. Thompson, W.W., M. Keating), Biostatistics (P. Thall), Laboratory Medicine (K.C.), Hematopathology (E.N.C.), and Lymphoma and Myeloma (S.N., M.W.), University of Texas M.D. Anderson Cancer Center, Houston.

Funder

M.D. Anderson Cancer Center CLL and lymphoma Moonshot Grants

National Institutes of Health

Publisher

Massachusetts Medical Society

Subject

General Medicine

Link

http://www.nejm.org/doi/pdf/10.1056/NEJMoa1910607

Cited by 1408 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. GD2 targeting CAR T cells for neuroblastoma;EJC Paediatric Oncology;2024-12

2. Potential alternatives to αβ-T cells to prevent graft-versus-host disease (GvHD) in allogeneic chimeric antigen receptor (CAR)-based cancer immunotherapy: A comprehensive review;Pathology - Research and Practice;2024-10

3. Left out in the cold: Moving beyond hormonal therapy for the treatment of immunologically cold prostate cancer with CAR T cell immunotherapies;The Journal of Steroid Biochemistry and Molecular Biology;2024-10

4. A scalable, spin‐free approach to generate enhanced induced pluripotent stem cell–derived natural killer cells for cancer immunotherapy;Immunology & Cell Biology;2024-09-13

5. Peripheral NK cell phenotypic alteration and dysfunctional state post hepatitis B subviral particles stimulation in CHB patients: evading immune surveillance;Frontiers in Immunology;2024-09-12